search
Back to results

Laparoscopic Guided Transversus Abdominis Plane Block for Postoperative Analgesia After Pediatric Laparoscopic Surgery. (TAB)

Primary Purpose

Analgesia

Status
Unknown status
Phase
Phase 2
Locations
Egypt
Study Type
Interventional
Intervention
TAB Block
Psoas Block
Bupivacaine
Sponsored by
Assiut University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Analgesia

Eligibility Criteria

1 Year - 6 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Children (1-6 years) of both sexes undergoing elective laparoscopic surgeries that last >30minutes (eg. undescended testis and inguinal hernia repair).
  • Written consent, free and informed

Exclusion Criteria:

  • Significant respiratory, cardiac or renal disease
  • BMI >95th percentile for age.

Sites / Locations

  • Pediatric hospital, faculty of medicine, Assiut universityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

TAB Block

Psoas Block

Arm Description

Patients will recieve 0.3ml/kg bupivacaine 0.25% on each side for laparoscopically guided Transversus abdominis plane block.

Patients will recieve 0.3ml/kg bupivacaine 0.25% on each side for laparoscopically guided psoas block.

Outcomes

Primary Outcome Measures

FLACC PAIN score
postoperative FLACC pain scores.

Secondary Outcome Measures

Full Information

First Posted
December 25, 2017
Last Updated
July 13, 2020
Sponsor
Assiut University
search

1. Study Identification

Unique Protocol Identification Number
NCT03388671
Brief Title
Laparoscopic Guided Transversus Abdominis Plane Block for Postoperative Analgesia After Pediatric Laparoscopic Surgery.
Acronym
TAB
Official Title
Laparoscopic Guided Transversus Abdominis Plane Block for Postoperative Analgesia After Pediatric Laparoscopic Surgery.
Study Type
Interventional

2. Study Status

Record Verification Date
July 2020
Overall Recruitment Status
Unknown status
Study Start Date
December 25, 2017 (Actual)
Primary Completion Date
December 2020 (Anticipated)
Study Completion Date
December 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Assiut University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The aim of this study will be to investigate the safety and analgesic efficacy of Transversus Abdominis Plane (TAB) Block versus psoas block blockade. Both blocks will be administered surgically and guided by the laparoscopy screen in children undergoing laparoscopic surgery.
Detailed Description
Transversus abdominis plane (TAP) block is a promising effective method for postoperative pain control after major abdominal surgery. TAP block provides analgesia by inhibiting nerve conduction from the anterior abdominal wall arising from the intercostal nerves, subcostal nerves, and first lumbar nerve (T6-L1). Using a landmark technique, it is easily performed, but its popularity has decreased because of reduced efficacy due to inaccurate injection and the potential for intra-peritoneal organ damage. Ultrasound-guided TAP block provides better results and fewer complications, but it requires experienced operators. Surgically administered TAP (sTAP) block guided by the video camera of the laparoscope is a simple technique and may cause no complications. Also, under laparoscopic guidance, block of ilioinguinal, iliohypogastric, and genitofemoral nerves can be possible with anesthetic injection in the plane between psoas major and the fasciae covering its anterior aspects [laparoscopic-assisted psoas (LAP) blockade].

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Analgesia

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Model Description
The aim of this study will be to investigate the safety and analgesic efficacy of Transversus Abdominis Plane (TAB) Block versus psoas blocks. Both blocks will be administered surgically and guided by the laparoscopy screen in children undergoing laparoscopic surgery.
Masking
ParticipantOutcomes Assessor
Masking Description
The data collection personnel and the patients' guardians will be blinded to the group assignment.
Allocation
Randomized
Enrollment
44 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
TAB Block
Arm Type
Active Comparator
Arm Description
Patients will recieve 0.3ml/kg bupivacaine 0.25% on each side for laparoscopically guided Transversus abdominis plane block.
Arm Title
Psoas Block
Arm Type
Active Comparator
Arm Description
Patients will recieve 0.3ml/kg bupivacaine 0.25% on each side for laparoscopically guided psoas block.
Intervention Type
Procedure
Intervention Name(s)
TAB Block
Intervention Description
patients will recieve 0.3ml/kg bupivacaine 0.25% on each side for laparoscopically guided TAB Block
Intervention Type
Procedure
Intervention Name(s)
Psoas Block
Intervention Description
patients will recieve 0.3ml/kg bupivacaine 0.25% on each side for laparoscopically guided Psoas Block
Intervention Type
Drug
Intervention Name(s)
Bupivacaine
Other Intervention Name(s)
Bucain
Intervention Description
patients will recieve 0.3ml/kg bupivacaine 0.25% on each side for laparoscopically guided Psoas Block or TAB block
Primary Outcome Measure Information:
Title
FLACC PAIN score
Description
postoperative FLACC pain scores.
Time Frame
36hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
1 Year
Maximum Age & Unit of Time
6 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Children (1-6 years) of both sexes undergoing elective laparoscopic surgeries that last >30minutes (eg. undescended testis and inguinal hernia repair). Written consent, free and informed Exclusion Criteria: Significant respiratory, cardiac or renal disease BMI >95th percentile for age.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Hala S Abdelghaffar, MD
Phone
01003812011
Ext
+2088
Email
hallasaad@yahoo.com
First Name & Middle Initial & Last Name or Official Title & Degree
Seham M Moeen, MD
Phone
01006386324
Ext
+2088
Email
seham.moeen@yahoo.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hala S Abdelghaffar, MD
Organizational Affiliation
Professor in anesthesia and intensive care department, faculty of medicine, Assiut university, Egypt.
Official's Role
Principal Investigator
Facility Information:
Facility Name
Pediatric hospital, faculty of medicine, Assiut university
City
Assiut
State/Province
Assiut Governorate
ZIP/Postal Code
715715
Country
Egypt
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hala S Abdelghaffar, MD
Phone
+201003812011
Email
hallasaad@yahoo.com
First Name & Middle Initial & Last Name & Degree
Seham M Moeen, MD
Phone
01006386324
Email
seham.moeen@yahoo.com

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Laparoscopic Guided Transversus Abdominis Plane Block for Postoperative Analgesia After Pediatric Laparoscopic Surgery.

We'll reach out to this number within 24 hrs